Valuation: Olympus Corporation

Market Cap 2,151B 13.67B 12B 11.33B 10.32B 19.33B 1,310B 19.46B 136B 52.51B 669B 51.32B 50.21B P/E 2027 *
20.6x
P/E 2028 * 17.7x
Enterprise Value 2,235B 14.2B 12.46B 11.77B 10.73B 20.08B 1,361B 20.22B 141B 54.55B 695B 53.32B 52.17B EV / Sales 2027 *
2.07x
EV / Sales 2028 * 1.97x
Free-Float
94.58%
Yield 2027 *
1.51%
Yield 2028 * 1.58%
1 day+1.45%
1 week+0.95%
Current month-3.87%
1 month-5.11%
3 months+20.19%
6 months+41.34%
Current year+1.99%
1 week 1,985
Extreme 1985
2,040.5
1 month 1,892
Extreme 1892
2,167.5
Current year 1,302.5
Extreme 1302.5
2,210.5
1 year 1,302.5
Extreme 1302.5
2,210.5
3 years 1,302.5
Extreme 1302.5
2,867
5 years 1,302.5
Extreme 1302.5
3,198
10 years 758.75
Extreme 758.75
3,198
Manager TitleAgeSince
Chief Executive Officer 63 2025-05-31
Director of Finance/CFO 59 2026-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 41 2019-05-31
Director/Board Member 63 2019-05-31
Director/Board Member 59 2021-06-24
Change 5-day change 1-year change 3-year change Capi.($)
+1.45%+0.95%+7.52%+1.28% 13.67B
-0.50%+3.62%+45.40%+34.57% 250B
+0.32%+5.99%+21.45%-9.21% 158B
+1.42%+3.01%-8.15%+39.36% 143B
-1.70%+1.34%-55.27%-16.87% 63.65B
+0.65%-2.23%+13.17%+22.62% 49.74B
-0.03%+10.43%+40.04%+56.05% 48.71B
+1.56%+0.05%-16.49%-20.14% 47.94B
+0.75%+2.82%+48.62%+61.74% 42.59B
-1.42%+12.68%+194.47%+109.45% 40.77B
Average +0.25%+3.90%+29.08%+27.89% 85.76B
Weighted average by Cap. +0.14%+4.14%+25.59%+25.35%

Financials

2027 *2028 *
Net sales 1,082B 6.88B 6.04B 5.7B 5.19B 9.72B 659B 9.79B 68.21B 26.42B 337B 25.82B 25.26B 1,124B 7.14B 6.27B 5.92B 5.39B 10.09B 684B 10.17B 70.81B 27.43B 350B 26.81B 26.23B
Net income 106B 670M 588M 556M 506M 948M 64.26B 955M 6.65B 2.58B 32.83B 2.52B 2.46B 122B 775M 680M 643M 586M 1.1B 74.32B 1.1B 7.69B 2.98B 37.97B 2.91B 2.85B
Net Debt 83.87B 533M 468M 442M 403M 753M 51.08B 759M 5.29B 2.05B 26.1B 2B 1.96B 65.49B 416M 365M 345M 314M 588M 39.89B 593M 4.13B 1.6B 20.38B 1.56B 1.53B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
26-09-25 JP¥2,024.00 +1.45% 3,524,800
26-09-24 JP¥1,995.00 -0.50% 3,766,200
26-09-18 JP¥2,005.00 -0.94% 5,796,800
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,024.00JPY
Average target price
2,184.62JPY
Spread / Average Target
+7.94%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7733 Stock